Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744744 · ClinicalTrials.gov registry record
Health-Related Quality of Life in Patients With Bladder Cancer
A clinical trial of Bladder Cancer, sponsored by David Latini.
- Completed
- Registry status
- 138
- Enrollment target
- 1
- Study location
NCT00744744 is a study of Bladder Cancer that has completed, run by David Latini. The registered enrollment target is 138 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00744744, a study of Bladder Cancer, has completed, sponsored by David Latini.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Gathering information about quality of life in patients with cancer may improve the ability to plan treatment and may help patients live more comfortably. PURPOSE: This clinical trial is studying health-related quality of life in patients with bladder cancer.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- PROCEDURE psychosocial assessment and care
- PROCEDURE management of therapy complications
- OTHER informational intervention
Study Locations (1)
Texas
- Dan L. Duncan Cancer Center at Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744744
The ClinicalTrials.gov registry entry for NCT00744744 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The listed sponsor is David Latini, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00744744 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00744744 about?
NCT00744744 is a clinical study titled "Health-Related Quality of Life in Patients With Bladder Cancer". RATIONALE: Gathering information about quality of life in patients with cancer may improve the ability to plan treatment and may help patients live more comfortably. PURPOSE: This clinical trial is studying health-related quality of life in patients with bladder cancer.
What is the current status of trial NCT00744744?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2008-05. Estimated completion is 2011-07.
What conditions does trial NCT00744744 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT00744744?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE), management of therapy complications (PROCEDURE), informational intervention (OTHER).
Who is sponsoring clinical trial NCT00744744?
This trial is sponsored by David Latini, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00744744 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.